News

Foamix Pharmaceuticals Ltd. announced that it has entered into a long term contract manufacturing and supply agreement with ASM Aerosol-Service for the Company’s recently approved…
Read More...

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, announced it has entered into…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Type II Variation Application to the European Medicines Agency (EMA) seeking first-in-class…
Read More...

PDS Biotechnology Corporation announced that it has completed manufacturing of clinical batches of PDS0101 with its partner BSP Pharmaceuticals S.p.A, a leading manufacturer of…
Read More...

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,…
Read More...

Zealand Pharma A/S, a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces the acquisition of Encycle…
Read More...

Takeda Pharmaceutical Company Limited and COUR Pharmaceutical Development Company, Inc. announced that Takeda has acquired an exclusive global license to develop and commercialize the…
Read More...

Biogen and Eisai, Co., Ltd. announced that, after consulting with the U.S. Food and Drug Administration (FDA), Biogen plans to pursue regulatory approval for aducanumab, an…
Read More...

Bryn Pharma announced that it has entered into an agreement with Aptar Pharma, a leading drug delivery systems provider, for the supply and worldwide exclusive right to use Aptar's…
Read More...

Moberg Pharma AB has signed a distribution agreement with DongKoo Bio & Pharma Co., Ltd for MOB-015 in the Republic of Korea. Under the agreement DongKoo is granted exclusive rights…
Read More...

Odonate Therapeutics, a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced the…
Read More...

Knight Therapeutics Inc. announced that it has entered into a definitive agreement under which Knight will acquire a 51.21% interest in Biotoscana Investments S.A. (B3: GBIO33) from a…
Read More...

GlaxoSmithKline plc announced the divestment of travel vaccines Rabipur (tradename Rabavert in the US) for the prevention of rabies, and Encepur for the prevention of tick-borne…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has approved Farxiga (dapagliflozin) to reduce the risk of hospitalisation for heart failure (hHF) in adults with…
Read More...

Verseau Therapeutics, Inc. launched with $50 million in financing from 20/20 HealthCare Partners, 3SBio, Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd., The…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Food and Drug Administration's (FDA) approval of STELARA® (ustekinumab) for the treatment of adult…
Read More...

Biogen Inc. and Samsung Bioepis announced that they will present new real-world data from the companies’ anti-TNF biosimilar portfolio, which includes FLIXABI (infliximab) and IMRALDI…
Read More...

Alexion Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved ULTOMIRIS (ravulizumab-cwvz) for the treatment of atypical hemolytic uremic syndrome (aHUS)…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a…
Read More...

Thermo Fisher Scientific, the world leader in serving science, announced the availability of the Thermo Scientific Acrometrix BCR-ABL Panel, its latest molecular quality control panel.…
Read More...